• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Aminopyrimidines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Aminopyrimidines and derivatives

Recent Advances in the Study of 2-Chloro-N-methylpyrimidin-4-amine (CAS: 66131-68-8)

2-Chloro-N-methylpyrimidin-4-amine (CAS: 66131-68-8) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential applications in drug discovery. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

A recent study published in the Journal of Medicinal Chemistry explored the use of 2-Chloro-N-methylpyrimidin-4-amine as a building block for the development of novel kinase inhibitors. The researchers demonstrated that this compound can be efficiently functionalized to target specific kinases involved in cancer progression. The study reported a series of derivatives with improved selectivity and potency, paving the way for further optimization in preclinical models.

Another significant advancement was reported in a 2023 paper in Bioorganic & Medicinal Chemistry Letters, where 2-Chloro-N-methylpyrimidin-4-amine was utilized in the synthesis of dual inhibitors targeting both EGFR and HER2 receptors. The study highlighted the compound's role in achieving high binding affinity and selectivity, which are critical for reducing off-target effects in cancer therapy. The results suggest that this intermediate could be a valuable tool in the design of next-generation targeted therapies.

In addition to its applications in oncology, recent research has also explored the potential of 2-Chloro-N-methylpyrimidin-4-amine in the development of antiviral agents. A study published in Antiviral Research demonstrated that derivatives of this compound exhibit inhibitory activity against RNA-dependent RNA polymerase (RdRp), a key enzyme in the replication of several RNA viruses. This finding opens new avenues for the development of broad-spectrum antiviral drugs.

From a synthetic chemistry perspective, advancements in the scalable production of 2-Chloro-N-methylpyrimidin-4-amine have been reported. A 2023 patent application detailed an optimized synthetic route that improves yield and reduces the use of hazardous reagents, addressing some of the challenges associated with its industrial-scale production. This development is expected to facilitate broader access to this important intermediate for research and drug development purposes.

In conclusion, recent studies underscore the growing importance of 2-Chloro-N-methylpyrimidin-4-amine (CAS: 66131-68-8) in medicinal chemistry and drug discovery. Its versatility as a synthetic intermediate and its potential in various therapeutic areas make it a compound of significant interest for future research. Continued exploration of its derivatives and applications is likely to yield further breakthroughs in the coming years.

• 7461-50-9(2-chloropyrimidin-4-amine)
• 56864-96-1(4-Pyrimidinamine,2-chloro-N,5-dimethyl-)
• 86443-51-8(2-Chloro-N-ethylpyrimidin-4-amine)
• 71406-72-9((2-Chloropyrimidin-4-yl)isopropylamine)
• 6973-00-8(4,6-Pyrimidinediamine,N4-methyl-, hydrochloride (1:1))
• 32998-03-1(2,6-Dichloro-N-methylpyrimidin-4-amine)
• 31058-81-8(2-Chloro-N,N-dimethylpyrimidin-4-amine)
• 27184-07-2(Pyrimidine,4,6-bis(1-aziridinyl)-2-chloro-)
• 17587-95-0(2-Chloro-N4-methylpyrimidine-4,5-diamine)
• 191728-83-3(2-Chloro-N-phenylpyrimidin-4-amine)